Cranial ultrasound may replace temporal artery biopsy in diagnosis of giant cell arteritis

Non-invasive test more sensitive and equally specific compared to current gold standard

2014-06-12

(Press-News.org) A new study presented for the first time today at the European League Against Rheumatism Annual Congress (EULAR 2014), shows that cranial ultrasound has a greater sensitivity than temporal artery biopsy,* and a comparable specificity in the diagnosis of Giant Cell Arteritis (GCA).1

Giant Cell Arteritis (GCA), a condition in which medium and large arteries mainly in the head and neck, become inflamed and narrowed, can cause blindness due to occlusion of the artery supplying the back of the eye. It is therefore essential that a prompt, accurate diagnosis of GCA is made and treatment with high dose steroids started as soon as possible. Currently there are no 100% accurate diagnostic tests for GCA. Patients typically present with severe headache and scalp tenderness located to one or both sides of the forehead. However, GCA can be difficult to distinguish from other less serious causes of headache.

In this study, cranial ultrasound was the strongest predictor for a diagnosis of GCA when results were evaluated against a confirmed clinical diagnosis at three months. In contrast, the existing American College of Rheumatology (ACR) criteria that include TAB,† when used alone, were insufficiently specific to accurately predict or exclude the diagnosis of GCA at three months. Relying on ACR criteria alone would therefore be leaving patients at risk of missing out on potentially sight-saving steroid treatment, or of being treated with high dose steroids unnecessarily. "Although temporal artery biopsy (TAB) has historically been considered the 'gold standard' diagnostic test for GCA, the exciting results of this new study suggest cranial ultrasound may soon replace TAB in the assessment of patients with a suspected diagnosis of GCA in routine clinical practice," said lead author Dr Adam Croft from the Centre for Translational Inflammation Research, University of Birmingham, UK.

"Patients with symptoms and signs of GCA can now be offered a much simpler, more accurate diagnostic test. The high predictive accuracy of cranial ultrasound over temporal artery biopsy indicated that temporal artery biopsy may now be unnecessary, particularly where clinical suspicion of GCA is high or quite low," Dr Croft added.

Out of a total of 87 patients who underwent cranial ultrasound for suspected GCA, 36 patients (41%) had a confirmed clinical diagnosis at the three month follow-up. Of the 30 patients who had a positive cranial ultrasound, 29 (96%) went on to have a confirmed diagnosis of GCA at three months. Of the 36 patients with more than three ACR criteria†, only 21 (58%) had a diagnosis of GCA confirmed at three months.

"Being able to reliably confirm the diagnosis is important not just to ensure those patients with GCA receive high-dose steroids to help prevent blindness, but also to prevent patients who don't have GCA continuing high-dose steroid therapy unnecessarily. High doses of steroids can cause a variety of unpleasant side effects including weight gain, infection risk, osteoporosis and fracture risk, high blood pressure, diabetes, cataracts," Dr Adam Croft explained.

When compared to clinical diagnosis at three months, the sensitivity of cranial ultrasound was 81%, specificity 98%, positive likelihood ratio 41, negative likelihood ratio 0.2, positive predictive value of 97% and negative predictive value of 88%. In contrast, when compared to clinical diagnosis at three months TAB had a sensitivity of 53%, specificity 100%, positive likelihood ratio 2.3, negative likelihood ratio 0.2, positive predictive value of 100% and negative predictive value of 47%. Over the last 25󈞊 years, GCA has been found to be the most common type of vasculitis in Europe and North America, especially in people aged >70 years. GCA mainly affects white individuals, and it almost exclusively occurs in subjects aged >50 years. The cause of giant cell arteritis is unclear; however, it is thought that a combination of genetic and environmental factors, such as an infection may be responsible.2 Prompt treatment of GCA with high dose steroids is essential to prevent permanent loss of vision. In one study, 14% permanently lost vision because of GCA, and in 94% of these patients the visual deficit developed before steroid therapy for GCA was begun.3

In this study, all patients undergoing cranial ultrasound between January 2005 and July 2013 were identified and clinical data obtained from electronic records, and, if necessary primary care providers. ACR criteria for GCA were used to classify patients.

Ultrasound reports were independently classified according to whether there was evidence of an arteritis or not. Explicit ultrasound features of GCA, such as a halo sign were not required to make this determination. The relationship between the ACR criteria alone or in combination with ultrasound and a final clinical diagnosis of GCA (made after a minimum of three-month follow-up) was analysed. A clinical diagnosis of GCA after three months of follow up served as the gold standard. The sensitivity and specificity of cranial ultrasound and of TAB were examined against this gold standard.

INFORMATION: Abstract Number: OP0056

NOTES TO EDITORS: For further information on this study, or to request an interview with the study lead, please contact us via: EULAR congress Press Office: Room 104, Palais des congrès de Paris Email: eularpressoffice@cohnwolfe.com Onsite tel: +44 (0) 7880 173209 Twitter: @EULAR_Press

About EULAR The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with rheumatic diseases throughout Europe.

EULAR aims to promote, stimulate and support the research, prevention, and treatment of rheumatic diseases and the rehabilitation of those it affects. With 45 scientific member societies, 35 People with Arthritis and Rheumatism in Europe (PARE) organisations, 17 health professionals associations and 26 corporate members, EULAR highlights the importance of combating rheumatic diseases through both medical means and patient care.

EULAR 2014 is set to be the biggest rheumatology event in Europe with almost 14,000 scientists, physicians, allied health professionals and related audiences in attendance from 130 countries. Over the course of the congress there will be 302 oral and 1,806 poster abstract presentations, 155 sessions, 725 lectures, 33 poster tours with 421 invited speakers. To find out more about the activities of EULAR, visit: http://www.eular.org

1Croft A, Thompson N, Duddy M. et al. Can we replace temporal artery biopsy with cranial ultrasound for the diagnosis of giant cell arteritis? A retrospective cohort study of the diagnostic utility of ultrasound in routine clinical practice. EULAR 2014; Paris: Abstract OP0056 2 Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009; 61(10):1454-61 3 Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993 Apr;100(4):550-5

* minor procedure performed under local anaesthetic to remove a sample of one of the scalp arteries † Three or more of the following: age ≥ 50; new onset headache; tenderness or reduced pulsation of the temporal artery; elevated blood erythrocyte sedimentation rate; and positive TAB

ELSE PRESS RELEASES FROM THIS DATE:

New study sheds light on what happens to 'cool' kids

2014-06-12

Teens who tried to act cool in early adolescence were more likely than their peers who didn't act cool to experience a range of problems in early adulthood, according to a new decade-long study. The study, by researchers at the University of Virginia, appears in the journal Child Development. While cool teens are often idolized in popular media—in depictions ranging from James Dean's Rebel Without a Cause to Tina Fey's Mean Girls—seeking popularity and attention by trying to act older than one's age may not yield the expected benefits, according to the study. Researchers ...

Toddlers whose parents use subsidies to buy center-based care more likely to enroll in Head Start

2014-06-12

Children of parents who use subsidies to purchase center-based care in the toddler years are more likely to be enrolled in Head Start or public prekindergarten in their preschool years, according to a new study. The research, conducted at Georgetown University and Columbia University, appears in the journal Child Development. The federally funded child care subsidy program—the Child Care and Development Fund (CCDF)—serves nearly 2 million children a month and is one of the government's biggest investments in the early care and education of low-income children. While the ...

Cancer drug boosts levels of vascular-protective gene, KLF2

2014-06-12

Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots. In 2008, the Food and Drug Administration approved bortezomib (Velcade) to treat multiple myeloma, which is a type of bone cancer and mantle cell lymphoma — a particularly aggressive form of non-Hodgkin lymphoma. In addition to attacking cancer cells, the drug has been shown to help prevent clot development common to many forms of the disease. As hematologist Lalitha ...

Childhood cancer survivors hospitalized frequently years after cancer treatment

2014-06-12

PHILADELPHIA — Survivors of childhood cancers were hospitalized more often and for longer durations because of blood disorders and other problems, many years after cancer treatment was completed, compared with the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "Our findings demonstrate that childhood cancer survivors face ongoing problems that can lead to hospitalization, even for those who are decades past their original cancer diagnosis. This can negatively ...

6,000 steps a day keeps knee OA limitations away

2014-06-12

A new study shows that walking reduces risk of functional limitation associated with knee osteoarthritis (OA). In fact, the study funded in part by grants from the National Institutes of Health (NIH) and published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, suggests that walking 6,000 or more steps per day may protect those with or at risk of knee of OA from developing mobility issues, such as difficulty getting up from a chair and climbing stairs. Nearly 27 million Americans age 25 and older are diagnosed with OA according to a ...

Low cholesterol linked with worse survival in patients with kidney cancer

2014-06-12

People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer. Increasing evidence suggests that alterations in cholesterol and other lipids are associated with the development, progression, and prognosis of various cancers. To assess the situation as it relates to kidney cancer, ...

Scientists weed out pesky poison ivy with discovery of killer fungus

2014-06-12

Much to the chagrin of gardeners, hikers, and virtually anyone enjoying the outdoors, one of the hazards of summer is picking up an itchy poison ivy rash. But researchers in the Virginia Tech College of Agriculture and Life Sciences have found a natural and effective way to kill poison ivy using a naturally occurring fungus that grows on the fleshy tissue surrounding the plant's seed, potentially giving homeowners and forest managers the ability to rid landscapes of the pernicious pest. Their findings could make the maddening itch of the summer season a thing of the ...

Content kingmaker -- quality or webpage position?

2014-06-12

In today's Information Age, it's easy get overwhelmed by online content. On YouTube alone, over 100 hours worth of video is uploaded every minute. Showcasing the most interesting content allows providers to convey a certain level of quality to its audiences and encourages users to stay on the website, consuming content and winning advertising dollars for its provider. However, this influx of information makes it difficult for both content providers and users to determine what is interesting and worth consuming. Due to the sheer volume of submitted content, some providers ...

Spectrum Health among first to implant neurostimulator for epilepsy

2014-06-12

GRAND RAPIDS, Mich., June 11, 2013 – Spectrum Health is the first health system in Michigan and among the first in the nation to successfully implant a recently FDA-approved device that uses electric stimulation of the brain to treat adult epilepsy patients whose seizures have not responded to medication. The NeuroPace® Responsive Neurostimulation (RNS®) System is an implantable therapeutic device designed to detect abnormal electrical activity in the brain and respond by delivering imperceptible electrical stimulation to normalize brain activity before an individual ...

Peer influence leads teens to start, stop smoking -- but effect is stronger for starting

2014-06-11

WASHINGTON, DC, June 11, 2014 — Adolescents tend to be more powerful in influencing their friends to start smoking than in helping them to quit, according to sociologists. In a study of adolescent friendship networks and smoking over time, the researchers found that friends exert influence on their peers to both start and quit smoking, but the influence to start is stronger. "What we found is that social influence matters — it leads nonsmoking friends into smoking and nonsmoking friends can turn smoking friends into nonsmokers," said Steven Haas, an associate professor ...

Cranial ultrasound may replace temporal artery biopsy in diagnosis of giant cell arteritis

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: